RAPPORT THERAPEUTICS INC (RAPP) Forecast, Price Target & Analyst Ratings

NASDAQ:RAPP • US75383L1026

Current stock price

35.4 USD
-1.16 (-3.17%)
At close:
35.4 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for RAPPORT THERAPEUTICS INC (RAPP).

Forecast Snapshot

Consensus Price Target

Price Target
$53.27
+ 50.47% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 7, 2026
Period
Q1 / 2026
EPS Estimate
-$0.68
Revenue Estimate
10.2M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
85.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$53.27
Upside
+ 50.47%
From current price of $35.40 to mean target of $53.27, Based on 16 analyst forecasts
Low
$40.40
Median
$51.00
High
$84.00

Price Target Revisions

1 Month
1.95%
3 Months
-0.05%

Price Target Summary

16 Wall Street analysts provided a forecast for the next 12 months for RAPP. The average price target is 53.27 USD. This implies a price increase of 50.47% is expected in the next year compared to the current price of 35.4.
The average price target has been revised downward by 0.05% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

RAPP Current Analyst RatingRAPP Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8

Analyst Ratings History

RAPP Historical Analyst RatingsRAPP Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
85.00%
RAPP was analyzed by 16 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about RAPP.
In the previous month the buy percentage consensus was at a similar level.
RAPP was analyzed by 16 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-04-22BTIGReiterate Buy -> Buy
2026-03-11BTIGMaintains Buy -> Buy
2026-03-11Wells FargoMaintains Overweight -> Overweight
2026-02-02Wells FargoInitiate Overweight
2025-12-09HC Wainwright & Co.Maintains Buy -> Buy
2025-12-08BTIGReiterate Buy -> Buy
2025-11-19BTIGInitiate Buy
2025-11-07CitizensMaintains Market Outperform -> Market Outperform
2025-09-16Truist SecuritiesInitiate Buy
2025-09-08HC Wainwright & Co.Maintains Buy -> Buy
2025-08-06HC Wainwright & Co.Initiate Buy
2025-07-08JMP SecuritiesReiterate Market Outperform -> Market Outperform
2025-04-08JMP SecuritiesInitiate Market Outperform
2024-10-18Jones TradingInitiate Buy
2024-07-02TD CowenInitiate Buy
2024-07-02StifelInitiate Buy
2024-07-02JefferiesInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 7, 2026
Period
Q1 / 2026
EPS Estimate
-$0.68
Revenue Estimate
10.2M
Revenue Q2Q
N/A
EPS Q2Q
0.31%
Number of Analysts
11

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
13.50%

Next Earnings Summary

RAPP is expected to report earnings on 5/7/2026. The consensus EPS estimate for the next earnings is -0.68 USD and the consensus revenue estimate is 10.20M USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
RAPP revenue by date.RAPP revenue by date.
N/AN/A
-100.00%		N/AN/AN/AN/A
325.81%		N/A
229.03%		N/A
65.78%
EBITDA
YoY % growth
RAPP ebitda by date.RAPP ebitda by date.
-10.352M-36.067M
-248.41%		-82.216M
-127.95%		-124.082M
-50.92%		N/A
-53.21%		N/A
-35.07%		N/A
-46.87%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
RAPP ebit by date.RAPP ebit by date.
-10.367M-36.179M
-248.98%		-83.055M
-129.57%		-125.099M
-50.62%		N/A
-32.13%		N/A
-38.78%		N/A
-13.84%		N/A
-12.80%		N/A
14.77%		N/A
40.91%		N/A
279.11%		N/A
123.68%
Operating Margin
RAPP operating margin by date.RAPP operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
RAPP eps by date.RAPP eps by date.
N/AN/AN/A-2.86
24.22%		N/A
-19.13%		N/A
-29.96%		N/A
-13.06%		N/A
7.15%		N/A
27.48%		N/A
49.47%		N/A
301.05%		N/A
109.83%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.68
0.31%		-0.85
-13.00%		-0.96
-34.97%		-1.04
-43.95%		-1.10
-61.74%		-1.06
-24.57%		-1.09
-13.36%		-1.14
-9.73%
Revenue
Q2Q % growth		10.2M4.08M
-100.00%
-100.00%
EBITDA
Q2Q % growth		-39.476M
-46.95%		-47.139M
-62.55%		-49.702M
-70.01%		-53.792M
-43.48%		N/AN/AN/AN/A
EBIT
Q2Q % growth		-31.4M
-15.83%		-45.193M
-53.22%		-48.903M
-63.09%		-52.884M
-37.33%		-55.004M
-75.17%		-56.304M
-24.58%		-57.605M
-17.79%		-60.69M
-14.76%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

RAPP Yearly Revenue VS EstimatesRAPP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2026 2030 2031 2032 2033 200M 400M 600M 800M 1B
RAPP Yearly EPS VS EstimatesRAPP Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 -2 4 -4 6

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-20.52%
EPS Next 5 Year
-3.34%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-46.07%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

RAPPORT THERAPEUTICS INC / RAPP Forecast FAQ

Can you provide the average price target for RAPPORT THERAPEUTICS INC stock?

16 analysts have analysed RAPP and the average price target is 53.27 USD. This implies a price increase of 50.47% is expected in the next year compared to the current price of 35.4.

What is the next earnings date for RAPP stock?

RAPPORT THERAPEUTICS INC (RAPP) will report earnings on 2026-05-07.

What are the consensus estimates for RAPPORT THERAPEUTICS INC (RAPP) next earnings?

The consensus EPS estimate for the next earnings of RAPPORT THERAPEUTICS INC (RAPP) is -0.68 USD and the consensus revenue estimate is 10.20M USD.

What is the consensus rating for RAPP stock?

The consensus rating for RAPPORT THERAPEUTICS INC (RAPP) is 85 / 100 . This indicates that analysts generally have a positive outlook on the stock.